Recent News for BHC - Bausch Health Companies Inc.

Date Title
May 23 Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes
May 22 Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries
May 10 Bausch Health: Long-Term Promise or Stalled at the Top of the Range?
May 10 BHC’s Salix Segment: Xifaxan Drove Its Revenues in Q1
May 9 Bausch Health CEO: Most of our medicines aren't subject to U.S. drug regulations
May 9 Bausch Health Announces Pricing Of Private Offering Of Senior Notes
May 9 What’s BHC’s Major Revenue Driver in Fiscal 2019?
May 9 Bausch Health Companies’ Cash Flow Guidance in Fiscal 2019
May 9 Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series
May 9 Bausch Health Announces Launch Of Private Offering Of Senior Notes
May 9 Bausch Health Companies Reiterated Its Expense Guidance
May 8 Bausch Health Companies Raised Its Earnings Guidance
May 8 BHC: Higher Revenue Guidance for Fiscal 2019
May 8 BHC: Analysts’ Recommendations after Q1 Results
May 6 Why Bausch Health Companies, Aquantia, and Athenex Jumped Today
May 6 Bausch Health Companies Inc. (BHC) Q1 2019 Earnings Call Transcript
May 6 Drug Giant Reports Mixed First Quarter, But Raises Sales Outlook
May 6 Bausch Health Companies Posts Strongest Organic Growth in 3 Years
May 6 Bausch Health sheds light on Valeant's troubled past
May 6 Stocks making the biggest moves midday: Bausch Health, Anadarko Petroleum, Nvidia & more
May 6 Valeant’s Ugly Past Recedes for Its Successor Bausch
May 6 Bausch Health Stock Jumps as Earnings Help Put the Past in the Past
May 6 Bausch Health Rises After Trimming Loss, Raising Guidance
May 6 Bausch: 1Q Earnings Snapshot
May 6 Bausch Health, formerly known as Valeant Pharmaceuticals, shares jump after raising 2019 outlook
Back to the Main BHC Page...